Ignacio Rodríguez

ORCID: 0000-0002-6586-0111
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Reproductive Biology and Fertility
  • Assisted Reproductive Technology and Twin Pregnancy
  • Ovarian function and disorders
  • Prenatal Screening and Diagnostics
  • Endometriosis Research and Treatment
  • Ovarian cancer diagnosis and treatment
  • Gynecological conditions and treatments
  • Reproductive Health and Technologies
  • Pregnancy and preeclampsia studies
  • Uterine Myomas and Treatments
  • Endometrial and Cervical Cancer Treatments
  • Breast Cancer Treatment Studies
  • Cardiac electrophysiology and arrhythmias
  • Ultrasound and Hyperthermia Applications
  • Gestational Diabetes Research and Management
  • Breast Lesions and Carcinomas
  • Ectopic Pregnancy Diagnosis and Management
  • Congenital Anomalies and Fetal Surgery
  • Fetal and Pediatric Neurological Disorders
  • Parvovirus B19 Infection Studies
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrhythmias and Treatments
  • Birth, Development, and Health
  • Reproductive System and Pregnancy
  • Cardiac pacing and defibrillation studies

Hospital Universitario Dexeus
2016-2025

USP Institut Universitari Dexeus
2015-2024

Hospital Universitario Reina Sofía
2023

University of Aberdeen
2023

Weatherford College
2022

Technical University of Munich
2021

Instituto Politécnico Nacional
2021

Hospital Universitario La Paz
2001-2020

Universitat Autònoma de Barcelona
2007-2020

Roche (United States)
2009-2020

Women have a higher incidence of torsades de pointes than men, but it is not known if the risk drug-induced varies during menstrual cycle.To determine degree QT prolongation in response to ibutilide with cycle phase and compare between women men.Cohort study men who received same intervention conducted November 1998 2000 at general clinical research center university hospital.A volunteer sample 58 healthy adults (38 20 women) aged 21 40 years.A low dose (0.003 mg/kg), infused intravenously...

10.1001/jama.285.10.1322 article EN JAMA 2001-03-14

To establish the accuracy of three-dimensional ultrasound (3D-US), compared with magnetic resonance imaging (MRI), for diagnosing uterine anomalies, using European Society Human Reproduction and Embryology-European Gynaecological Endoscopy (ESHRE-ESGE) consensus on classification congenital anomalies female genital tract.Sixty women suspected after examination by conventional two-dimensional were evaluated 3D-US MRI. These data analyzed retrospectively to confirm presence type malformation...

10.1002/uog.14825 article EN Ultrasound in Obstetrics and Gynecology 2015-02-18

BackgroundEarly identification of women with an increased risk for preeclampsia is utmost importance to minimize adverse perinatal events. Models developed until now (mainly multiparametric algorithms) are thought be overfitted the derivation population, which may affect their reliability when applied other populations. Options allowing adaptation a variety populations needed.ObjectiveThe objective study was assess performance first-trimester multivariate Gaussian distribution model...

10.1016/j.ajog.2020.01.020 article EN cc-by-nc-nd American Journal of Obstetrics and Gynecology 2020-01-20

Abstract STUDY QUESTION Does an individualised luteal phase support (iLPS), according to serum progesterone (P4) level the day prior euploid frozen embryo transfer (FET), improve pregnancy outcomes when started on previous transfer? SUMMARY ANSWER Patients with low P4 FET can benefit from addition of daily subcutaneous injections (Psc), FET, and achieve similar reproductive compared those initial adequate levels. WHAT IS KNOWN ALREADY The ratio between FET/IVF has spectacularly increased in...

10.1093/humrep/deab031 article EN Human Reproduction 2021-02-03

Is there any relationship between the number of oocytes retrieved and cumulative live birth rates (CLBRs) in women advanced age?CLBRs increase with reproductive age up to 41 years old, added value is minimal more than futile 44 or older.CLBR actually most relevant outcome IVF from patients' perspective. There are several studies that have analysed CLBR's but some them included stimulation cycles, others not frozen embryo transfers (FETs) their analysis none has focused on age. We aimed...

10.1093/humrep/dey295 article EN Human Reproduction 2018-09-19

Is there any difference in ovarian response and embryo ploidy following progesterone-primed stimulation (PPOS) using micronized progesterone or GnRH antagonist protocol?

10.1093/humrep/deae047 article EN Human Reproduction 2024-03-18

To evaluate in our setting whether there is currently a level of P on the hCG day (P-hCG) predictive no pregnancy.Observational study prospectively collected data P-hCG levels stimulated IVF cycles.In vitro fertilization unit.All cycles IVF/intracytoplasmic sperm injection with fresh embryo transfer performed between January 2009 and March 2014.None.Pregnancy rate.Clinical pregnancy rate per ET was 38.7% live birth 29.1%. The concentration positively correlated to E2 day, number oocytes...

10.1016/j.fertnstert.2015.09.008 article EN publisher-specific-oa Fertility and Sterility 2015-10-13

This paper compares three candidate large-scale propagation path loss models for use over the entire microwave and millimeter-wave (mmWave) radio spectrum: alpha-beta-gamma (ABG) model, close-in (CI) free space reference distance CI model with a frequency-weighted exponent (CIF). Each of these have been recently studied in standards bodies such as 3GPP, design fifth generation (5G) wireless systems urban macrocell, microcell, indoor office shopping mall scenarios. Here we compare accuracy...

10.48550/arxiv.1603.04404 preprint EN other-oa arXiv (Cornell University) 2016-01-01

Nacubactam is a novel β-lactamase inhibitor with dual mechanisms of action as an serine β-lactamases (classes A and C some class D) penicillin binding protein 2 in Enterobacteriaceae The safety, tolerability, pharmacokinetics intravenous nacubactam were evaluated single- multiple-ascending-dose, placebo-controlled studies. Healthy participants received single ascending doses 50 to 8,000 mg, multiple 1,000 4,000 mg every 8 h (q8h) for up 7 days, or 2,000 plus meropenem q8h 6 days after 3-day...

10.1128/aac.02229-19 article EN cc-by Antimicrobial Agents and Chemotherapy 2020-02-11

Abstract Objective To examine the association between serum thyroid-stimulating hormone (TSH) levels with handgrip strength (HGS) and dynapenia in euthyroid postmenopausal women. Methods This was an exploratory cross-sectional study among 385 participants from Department of Obstetrics, Gynecology, Reproduction Dexeus Women's University Hospital, Barcelona, Spain. Age, age at menopause, adiposity, alcohol consumption, body mass index (BMI), smoking status were recorded. TSH determined by...

10.1097/gme.0000000000002499 article EN Menopause The Journal of The North American Menopause Society 2025-01-28
Coming Soon ...